These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 20481572)
1. Affinity of sulfamates and sulfamides to carbonic anhydrase II isoform: experimental and molecular modeling approaches. Gavernet L; Gonzalez Funes JL; Blanch LB; Estiu G; Maresca A; Supuran CT J Chem Inf Model; 2010 Jun; 50(6):1113-22. PubMed ID: 20481572 [TBL] [Abstract][Full Text] [Related]
2. Inhibition pattern of sulfamide-related compounds in binding to carbonic anhydrase isoforms I, II, VII, XII and XIV. Gavernet L; Gonzalez Funes JL; Palestro PH; Bruno Blanch LE; Estiu GL; Maresca A; Barrios I; Supuran CT Bioorg Med Chem; 2013 Mar; 21(6):1410-8. PubMed ID: 23266178 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements. Klinger AL; McComsey DF; Smith-Swintosky V; Shank RP; Maryanoff BE J Med Chem; 2006 Jun; 49(12):3496-500. PubMed ID: 16759092 [TBL] [Abstract][Full Text] [Related]
4. QSAR studies of sulfamate and sulfamide inhibitors targeting human carbonic anhydrase isozymes I, II, IX and XII. Tarko L; Supuran CT Bioorg Med Chem; 2013 Mar; 21(6):1404-9. PubMed ID: 23206986 [TBL] [Abstract][Full Text] [Related]
6. Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform. Maryanoff BE; McComsey DF; Costanzo MJ; Hochman C; Smith-Swintosky V; Shank RP J Med Chem; 2005 Mar; 48(6):1941-7. PubMed ID: 15771438 [TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors: inhibition of the β-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides. Vullo D; Leewattanapasuk W; Mühlschlegel FA; Mastrolorenzo A; Capasso C; Supuran CT Bioorg Med Chem Lett; 2013 May; 23(9):2647-52. PubMed ID: 23511020 [TBL] [Abstract][Full Text] [Related]
8. Examination of two independent kinetic assays for determining the inhibition of carbonic anhydrases I and II: structure-activity comparison of sulfamates and sulfamides. Shank RP; McComsey DF; Smith-Swintosky VL; Maryanoff BE Chem Biol Drug Des; 2006 Aug; 68(2):113-9. PubMed ID: 16999776 [TBL] [Abstract][Full Text] [Related]
9. QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices. Melagraki G; Afantitis A; Sarimveis H; Igglessi-Markopoulou O; Supuran CT Bioorg Med Chem; 2006 Feb; 14(4):1108-14. PubMed ID: 16213737 [TBL] [Abstract][Full Text] [Related]
10. A versatile polypeptide platform for integrated recognition and reporting: affinity arrays for protein-ligand interaction analysis. Enander K; Dolphin GT; Liedberg B; Lundström I; Baltzer L Chemistry; 2004 May; 10(10):2375-85. PubMed ID: 15146511 [TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316 [TBL] [Abstract][Full Text] [Related]
12. Residual ligand entropy in the binding of p-substituted benzenesulfonamide ligands to bovine carbonic anhydrase II. Stöckmann H; Bronowska A; Syme NR; Thompson GS; Kalverda AP; Warriner SL; Homans SW J Am Chem Soc; 2008 Sep; 130(37):12420-6. PubMed ID: 18717559 [TBL] [Abstract][Full Text] [Related]
13. Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: role of hydrogen-bonding networks in ligand binding and drug design. Abbate F; Supuran CT; Scozzafava A; Orioli P; Stubbs MT; Klebe G J Med Chem; 2002 Aug; 45(17):3583-7. PubMed ID: 12166931 [TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase II-induced selection of inhibitors from a dynamic combinatorial library of Schiff's bases. Nasr G; Petit E; Supuran CT; Winum JY; Barboiu M Bioorg Med Chem Lett; 2009 Nov; 19(21):6014-7. PubMed ID: 19796939 [TBL] [Abstract][Full Text] [Related]
15. Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa. Pinard MA; Lotlikar SR; Boone CD; Vullo D; Supuran CT; Patrauchan MA; McKenna R Bioorg Med Chem; 2015 Aug; 23(15):4831-4838. PubMed ID: 26068018 [TBL] [Abstract][Full Text] [Related]
16. Spectroscopic and molecular modeling studies on binding of dorzolamide to bovine and human carbonic anhydrase II. Bijari N; Ghobadi S; Mahdiuni H; Khodarahmi R; Ghadami SA Int J Biol Macromol; 2015 Sep; 80():189-99. PubMed ID: 26093313 [TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform II. Di Fiore A; Maresca A; Alterio V; Supuran CT; De Simone G Chem Commun (Camb); 2011 Nov; 47(42):11636-8. PubMed ID: 21952494 [TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. Nishimori I; Vullo D; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT J Med Chem; 2005 Dec; 48(24):7860-6. PubMed ID: 16302824 [TBL] [Abstract][Full Text] [Related]
19. 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity. Leese MP; Leblond B; Smith A; Newman SP; Di Fiore A; De Simone G; Supuran CT; Purohit A; Reed MJ; Potter BV J Med Chem; 2006 Dec; 49(26):7683-96. PubMed ID: 17181151 [TBL] [Abstract][Full Text] [Related]
20. Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II. Banerjee AL; Swanson M; Roy BC; Jia X; Haldar MK; Mallik S; Srivastava DK J Am Chem Soc; 2004 Sep; 126(35):10875-83. PubMed ID: 15339172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]